Nephros, Inc. (NEPH) Earnings Call Analysis

NASDAQ · Healthcare · Medical Instruments & Supplies

14/25

Growth 4 Margin 1 Expansion 5 Platform 2 Financial 2

latest quarter score

Earnings Reports

14
NEPH (NEPH) Q2 2026: Service Revenue Triples, Broadening Recurring Growth Base
August 07, 2026
16
Nephros (NEPH) Q1 2026: Programmatic Revenue Jumps 23% as Commercial Expansion Shifts Margin Structure
May 09, 2026
17
NEPH Q4 2025: Programmatic Revenue Surpasses 90%, Anchoring Recurring Growth Model
March 13, 2026
23
PACERA Biosciences (NEPH) Q3 2025: Exparel Volumes Jump 9% as GPO Strategy Drives Access and Margin Expansion
November 07, 2025
22
NEPH (NEPH) Q2 2025: Programmatic Sales Up 40% Two-Year CAGR, Driving Recurring Revenue Strength
August 14, 2025
19
Nephros (NEPH) Q1 2025: Record 38% Revenue Growth Driven by Programmatic and Emergency Demand
May 08, 2025
Nephros (NEPH) Q4 2024: 19% Revenue Growth Signals Programmatic Recovery and Market Expansion
March 06, 2025

Browse all companies